Semax

Semax
Semax is a synthetic heptapeptide derived from a fragment of the adrenocorticotropic hormone (ACTH4-10), modified to retain neuroactive properties without hormonal effects. Unlike endogenous ACTH, Semax does not stimulate corticosteroid release. Instead, it is considered a regulatory neuropeptide with potential cognitive, neuroprotective, and restorative properties. Researchers have investigated Semax primarily for its impact on central nervous system function, memory, and adaptive responses under stress conditions.

Overview
Semax is a synthetic heptapeptide (MEHFPGP) derived from the adrenocorticotropic hormone (ACTH 4-10) fragment, modified to enhance stability and activity. Unlike natural ACTH, Semax lacks hormonal activity but has been investigated for potential neuromodulatory and neuroprotective effects. Research suggests that Semax may modulate brain-derived neurotrophic factor (BDNF) expression and support pathways associated with memory, attention, and stress response. Its proposed mechanism involves influencing neurotransmitter systems such as dopamine, serotonin, and acetylcholine, which are considered critical in regulating sleep, learning, and cognitive performance.

Mechanism of Action
Semax is thought to interact with melanocortin receptors, potentially altering intracellular signaling cascades such as adenylate cyclase and cAMP-dependent pathways. Experimental data indicate that this may upregulate neurotrophins, particularly BDNF, contributing to synaptic plasticity and neuronal survival. By modulating these pathways, Semax has been studied for its potential to support circadian rhythm regulation and restorative processes tied to sleep.

Chemical Makeup

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Molecular Formula: C37H51N9O10
• Molecular Weight: 751.85 g/mol
• Appearance: White lyophilized powder
• Batch Purity (per COA): ≥ 99% (HPLC)

Research and Clinical Studies

Semax and Neuroprotection
Preclinical research has explored Semax for its potential to protect neurons from oxidative and ischemic stress. Models of cerebral ischemia suggest reduced lesion size and enhanced recovery of neurological functions after administration, potentially linked to antioxidative and anti-apoptotic signaling.

Semax and Cognitive Function
Studies have indicated that Semax may enhance learning and memory in animal models through BDNF-mediated mechanisms. In human research, it has been investigated for possible roles in improving attention, memory recall, and mental performance in settings of fatigue or stress.

Semax and Sleep-Wake Regulation
Evidence points to the possibility that Semax influences neurotransmitter systems that underlie sleep architecture. Dopamine and serotonin modulation are considered integral to both circadian rhythm and restorative sleep phases, suggesting an indirect role for Semax in regulating sleep quality and recovery.

Semax and Stress Response
Semax has been studied for its potential to regulate stress-induced behavioral and physiological responses. By influencing the hypothalamic–pituitary–adrenal (HPA) axis indirectly, it may promote homeostasis without acting as a hormone itself, offering a unique profile for research into stress-related sleep disruption.

References

1. Ashmarin, I.P., et al. (1997). Semax: biological activity and clinical application. Biochemistry (Moscow). https://pubmed.ncbi.nlm.nih.gov/9351793/
   
2. Myasoedov, N.F., et al. (2002). Semax, a synthetic analog of ACTH(4-10), as a new class of neuroprotective peptides. Pathophysiology. https://pubmed.ncbi.nlm.nih.gov/12445705/
   
3. Andreeva, L.A., et al. (2000). Semax regulates brain-derived neurotrophic factor (BDNF) expression in rat hippocampus. Neuroscience and Behavioral Physiology. https://pubmed.ncbi.nlm.nih.gov/10852156/
   
4. Ashmarin, I.P., & Kamensky, A.A. (1999). Semax and its cognitive effects in animal models. Journal of Neurochemistry. https://pubmed.ncbi.nlm.nih.gov/10432348/
   
5. Dolotov, O.V., et al. (2006). Effects of Semax on dopamine and serotonin turnover. Neuroscience and Behavioral Physiology. https://pubmed.ncbi.nlm.nih.gov/16933000/
   
6. Andreeva, L.A., et al. (2001). Neuroprotective properties of Semax in ischemia models. Neuroscience Research. https://pubmed.ncbi.nlm.nih.gov/11755168/
   
7. Ashmarin, I.P., et al. (2005). Semax as a regulator of stress-induced gene expression. Biochemistry (Moscow). https://pubmed.ncbi.nlm.nih.gov/15807639/
   
8. Inozemtseva, L.S., et al. (2015). Clinical application of Semax in cognitive impairment. Zhurnal Nevrologii i Psikhiatrii. https://pubmed.ncbi.nlm.nih.gov/26299838/
   
9. Dolotov, O.V., et al. (2011). Semax effects on neurotrophin signaling. Neuroscience Letters. https://pubmed.ncbi.nlm.nih.gov/21600236/
   
10. Myasoedov, N.F. (2018). Peptide regulation of cognitive processes: focus on Semax. Neurochemical Journal. https://pubmed.ncbi.nlm.nih.gov/30042569/